Drugs / calcium formyl tetrahydrofolate
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT04617821 Comparator | Sep 2021 → Sep 2024 | pancreatic adenocarcinoma | Fudan University | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | calcium formyl tetrahydrofolate | “Intravenous infusion of calcium formyl tetrahydrofolate (LV) for 2 h, day 1;” NCT04617821 ↗ |
| Route | Intravenous | “Intravenous infusion of calcium formyl tetrahydrofolate (LV) for 2 h, day 1;” NCT04617821 ↗ |